Saturday 17 October 2026
Export BGLC’s income statement to Excel — free account
BioNexus Gene Lab Corp.
BGLC Basic Materials Specialty Chemicals
BioNexus Gene Lab Corp.’s revenue for fiscal 2025 (year ended December 2025) was $7.4 million, down 21.9% from fiscal 2024. In the quarter to June 2026, revenue fell 96.6%, EPS grew 64.7% and free cash flow grew 44.3%, each against the same quarter a year earlier.
1.20
0.02
−1.64%
Follow BGLC
BioNexus Gene Lab Corp. (BGLC) P/E ratio
BioNexus Gene Lab Corp. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 9,802× (October 2022) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 485× | 134.46% |
| FY2020 | 207× | 0.00% |
| FY2019 | 207× | 0.00% |
| FY2018 | 207× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 29 more quarters | Free account |
Against its own ten years
Low 0.0×
High 9,802×
Ten-year median
0.0×
Current reading's percentile
57
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TSEOQ Trinseo PLC compare | n/m |
| CRKN Crown Electrokinetics Corp. compare | n/m |
| BGLC BioNexus Gene Lab Corp. | n/m |
| HGAS Global Gas Corporation compare | n/m |
| SNES Senestech, Inc. compare | n/m |
| LOOP Loop Industries, Inc. compare | n/m |
| BON Bon Natural Life Limited compare | 0.9× |
| CNEY CN Energy Group. Inc. compare | 2.3× |
| YMAT J-Star Holding Co., Ltd compare | — |
| Specialty Chemicals industry median | 25.4× |
| Basic Materials sector median | 19.5× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)